Featured Press

AEON Biopharma Appoints BOTOX® Therapeutic Head as President and Chief Executive Officer

May 13, 2019

NEWPORT BEACH, Calif.May 13, 2019  – ALPHAEON Corporation announced today that its Board of Directors has named Marc Forth as President and Chief Executive Officer of its newly established, wholly-owned subsidiary, AEON Biopharma, Inc. AEON Biopharma was established to independently pursue the rapidly growing, multi-billion-dollar, therapeutic toxin market. Therapeutic related applications represent greater than 60% of global neurotoxin segment revenues. Mr. Forth joins AEON Biopharma from Allergan, where he was Senior Vice President of Neurosciences, Urology and Medical Dermatology. Mr. Forth led, among other brands, BOTOX® Therapeutic, an organization with annual revenues of approximately $2 Billion.
~PRNewswire

Press Archive

May 13, 2019 |  AEON Biopharma Appoints BOTOX® Therapeutic Head as President and Chief Executive Officer

Dec 11, 2018 | Strathspey Crown Announces Issuance of US Patent for Digital Root Combinatorial Titration of Gene (DNA) Modulation Technologies

Dec 06, 2018 | Strathspey Crown Announces Issuance of US Patent for Gene Modulation of Cellular…

May 07, 2018 | Evolus Appoints Allergan Aesthetics Head as President and Chief Executive Office…

Feb 12, 2018 | Orange County Business Journal, Evolus Prices IPO

Feb 05, 2018 | Strathspey Crown Wins US Patent for Titration of Phenotypic (DNA) Expression

Jan 09, 2018 | Evolus, Inc. Files Registration Statement for Proposed Initial Public Offering

Sep 18, 2017 | CONCIERGE KEY Health To Launch On-Demand App To Healthcare Nationwide

Sep 11, 2017 | Strathspey Crown to Acquire ShoutMD From ALPHAEON Corporation

Sep 08, 2017 | Strathspey Crown Appoints Richard Afable, MD as a Senior Advisor

Jul 19, 2017 | Evolus Announces FDA Acceptance for Review of the Biologics License Application …

Jul 12, 2017 | Strathspey Crown LLC Announces Issuance of US Patent of the First Implantable In…

Apr 25, 2017 | Strathspey Crown Aligns Asset Portfolio

Aug 17, 2016 | ALPHAEON Appoints Murthy Simhambatla PhD as CEO and President

May 25, 2016 | ALPHAEON Announces CEO’s Transition to Vice Chairman of Board of Directors

May 04, 2016 | ALPHAEON Launches PROVOQUE™ Facial Serum

Apr 07, 2016 | ALPHAEON Announces Results from Two Phase III Trials of DWP-450 Botulinum Toxin …

Apr 04, 2016 | New Study Demonstrates the Superiority of Crosslinked Hyaluronic Acid in Improv…

Feb 02, 2016 | ALPHAEON Introduces skIN3, A New Cosmetic Line Featuring DermaTriPlex™, A Uniq…

Jan 28, 2016 | ALPHAEON STRENGTHENS GLOBAL LEADERSHIP WITH NEW SENIOR APPOINTMENTS

Jan 28, 2016 | ALPHAEON Strengthens its Technology Foundation by Acquiring Eveo

Jan 11, 2016 | Strathspey Crown Acquires Assets of Novus Via

Dec 18, 2015 | ALPHAEON Acquires Rocol SA

Dec 17, 2015 | ALPHAEON Closes Acquisition of LENSAR

Dec 17, 2015 | Strathspey Crown Announces Appointment of Murthy Simhambhatla, PhD, as Senior P…

Dec 15, 2015 | ALPHAEON and Zelegent Announce Exclusive Global Agreement to Commercialize Offic…

Dec 04, 2015 | ALPHAEON APPOINTS FORMER NEW MEXICO GOVERNOR BILL RICHARDSON AND SAILING CAPITAL…

Nov 16, 2015 | ALPHAEON to Acquire LENSAR

Nov 14, 2015 | ALPHAEON Announces Agreement with PhysIOL to Commercialize Advanced Trifocal IOL…

Nov 12, 2015 | ALPHAEON Announces Plan to Acquire Integrity Digital Solutions

Nov 12, 2015 | ALPHAEON Corporation Closes Series B Preferred Stock Financing

Nov 10, 2015 | Physician Recommended Nutriceuticals Receives U.S. Patent for its Unique 3:1 Ome…

Sep 08, 2015 | Strathspey Crown to Acquire Ophthalmic Distributor in Spain and Portugal, IMEX

Sep 08, 2015 | ALPHAEON LAUNCHES SHOUTMD 3.0, THE FIRST SOCIAL COMMERCE STORE FOR LIFESTYLE HEA…

Sep 01, 2015 | CKH Brochure

Jul 09, 2015 | ALPHAEON’s Innovative Approach to Skin Health has Arrived

May 15, 2015 | TouchMD Unveils New State-of-the-Art Platform at ASAPS

May 06, 2015 | ALPHAEON APPOINTS HON. CHRISTOPHER COX AND DENNIS WOLF TO BOARD OF DIRECTORS

Apr 24, 2015 | ALPHAEON COMPLETES ENROLLMENT IN US PIVOTAL TRIALS FOR EVOLUS NEUROMODULATOR

Apr 17, 2015 | PRN’s Omega-3 Hits Major Endpoints Against Placebo in a Study of Dry Eye Symptom…

Apr 16, 2015 | ALPHAEON EXPANDS ALPHAEONMD PRACTICE SYSTEM WITH LAUNCH OF ENGAGEMD

Jan 28, 2015 | ALPHAEON™ appoints Jeff Castillo as President of the Americas and Kuntal Joshi…

Jan 22, 2015 | ALPHAEON™ Begins Phase III Study for its Neurotoxin, Evosyal

Jan 16, 2015 | ALPHAEON™ Partners with Tracey Technologies to Sell Next-Generation iTrace Pla…

Jan 15, 2015 | ALPHAEON™ Closes Series A Preferred Stock Financing in a Transaction Led By Lo…

Jan 05, 2015 | Strathspey Crown Appoints Brian J. Brille as Managing Partner

Dec 21, 2014 | Strathspey Crown: 2015’s Company to Watch

Dec 05, 2014 | ALPHAEON™ Completes Acquisition of Clarion Medical Technologies for $55 Millio…

Oct 10, 2014 | ALPHAEON™ Acquires TouchMD and Its State-of-the-Art Patient Consultation Platf…

Oct 09, 2014 | ALPHAEON™ Partners With Physician CEO Program

Oct 07, 2014 | Rival And BOTOX Go Cheek to Cheek

Sep 08, 2014 | ALPHAEON™ to Acquire Clarion Medical Technologies

Sep 04, 2014 | ALPHAEON™ FDA Accepts Investigational New Drug Application

Aug 25, 2014 | ALPHAEON™ Turns Innovation Into Reality With TEDxOrangeCoast

Aug 18, 2014 | ALPHAEON™ Seeks to Reward Innovative Teens

Jul 28, 2014 | ALPHAEON™ Acquires Leading Specialty Nutriceutical Company

May 15, 2014 | ALPHAEON™ Director to 2014 Power List

May 13, 2014 | ALPHAEON™ Appoints Board of Directors

Apr 25, 2014 | ALPHAEON™ Launches New Patient Financing Solution

Apr 25, 2014 | ALPHAEON™ Appoints Bob Rhatigan as COO

Apr 23, 2014 | ALPHAEON™ Expands Partnership with TEOXANE Laboratories

Apr 23, 2014 | ALPHAEON™ Launches State-of-the-Art Interactive Platform in Ophthalmaology

Feb 25, 2014 | Popular European Wrinkle Filler Making its Way to the U.S.

Dec 02, 2013 | ALPHAEON™ Named “Best Industry Start-Up of 2013”

Nov 25, 2013 | Laser Licensing Pushes ALPHAEON’s Middleman Method

Nov 19, 2013 | New Healthcare Company Allows Patients More Choices

Nov 13, 2013 | ALPHAEON™ Acquires Exclusive License to Advanced Technology For Vision Correct…

Nov 08, 2013 | ALPHAEON™ Puts Patients and Physicians back at the Center of Healthcare

Nov 05, 2013 | Products: Seeking ALPHAEON™

Oct 18, 2013 | Beautiful Minds are Free from Fear: Robert Grant at TEDx

Oct 13, 2013 | ALPHAEON™, backed by Strathspey Crown, to build specialty medical franchise wi…

Oct 10, 2013 | ALPHEON™ Acquires Exclusive Worldwide Licensing Rights To TouchMD™

Oct 09, 2013 | ALPHAEON™ to Launch the First Early Cataract Detection Device

Oct 03, 2013 | Strathspey Crown Acquires Evolus, Inc.

Aug 29, 2013 | Former Bausch & Lomb Exec Forms Health-Care Firm Targeting Cash-Pay Businesses

Aug 11, 2013 | ALPHAEON™ Corp. Goes to Switzerland for First Product

Aug 01, 2013 | ALPHAEON™ Acquires Exclusive U.S. License to Teoxane Laboratories’ Full Portfo…

Jul 23, 2013 | Corporate investment: A mysterious divergence

Jul 23, 2013 | Growth Equity Firm Launches ALPHAEON™ to Advance Products in Self-pay Healthca…

Jul 22, 2013 | Link Takes Personal Interest in Strathspey’s Self-Pay Plan

Jul 21, 2013 | Strathspey Crown Establishes ALPHAEON™ Corporation, The First Self-Pay Lifesty…

May 16, 2013 | Strathspey Crown Announces Appointment of Vikram Malik as a Managing Partner

Mar 18, 2013 | The American Society of Plastic Surgeons and Strathspey Crown Announce a Strateg…